More Complications, Less Satisfaction in Breast Cancer Patients Who Have Radiation and Implants

Researchers did not see these differences when radiation was added to autologous reconstruction.

10:30 AM

Author | Nicole Fawcett

A breast cancer patient deciding whether to get implant reconstruction to autologous reconstruction

Many breast cancer patients who have a mastectomy will consider breast reconstruction. But for a portion of these women, radiation therapy is also recommended — and that can alter the tissue around the breast, impacting reconstruction efforts.

MORE FROM THE LAB: Subscribe to our weekly newsletter

A new study finds that women who have implant reconstruction following radiation therapy had more complications from the surgery and were less satisfied with the result than women who had implants but no radiation.

Patients who received radiation followed by autologous reconstruction, in which flaps of the patient's own tissue are used to reconstruct the breast, reported complications and satisfaction similar to women who had this reconstruction but did not get radiation.

"Women diagnosed with early-stage breast cancer face challenging decisions that will impact both their long-term disease control and quality of life. These findings have considerable significance for those who have decided to receive post-mastectomy radiotherapy and must select a type of reconstruction," says study author Reshma Jagsi, M.D., D.Phil., professor and deputy chair of radiation oncology at the University of Michigan Medical School.

It is critical to use these results to generate consensus about the optimal approaches to integrating radiation therapy and breast reconstruction.
Reshma Jagsi, M.D., D.Phil.

Assessing outcomes             

The study looked at breast cancer patients from 11 institutions who had received mastectomy and reconstruction; 553 also had radiation and 1,461 did not.

SEE ALSO: Choosing Double Mastectomy, Even If Not Medically Necessary

Researchers used a number of measures to assess complications within one and two years of treatment as well as patient-reported satisfaction with their breasts.

After two years, 39 percent of patients receiving radiation and implants had at least one complication compared to 26 percent of patients receiving radiation and autologous reconstruction. Among patients who did not have radiation, 22 percent had complications with implants and 28 percent had complications with autologous reconstruction.

Similarly, patients receiving implants and radiation had significantly lower satisfaction than patients who had implants only, while patients who had autologous reconstruction reported similar satisfaction regardless of radiation treatment. Results will be presented at the San Antonio Breast Cancer Symposium.

"Autologous reconstruction is a much more extensive procedure. But given the findings in this study, it may be preferable for some patients, particularly those worried about the impact of radiation on the outcomes of reconstruction," Jagsi says.

The study was part of the Mastectomy Reconstruction Outcomes Consortium, or MROC, a prospective multicenter study led by Edwin Wilkins, M.D., professor of plastic surgery at the University of Michigan. The study is designed to evaluate breast reconstruction from the patient's point of view, tracking postoperative pain, psychosocial well-being, physical functioning, fatigue and patient satisfaction.

Growing evidence supports the benefits of post-mastectomy radiotherapy in appropriate patients. Reconstruction is associated with increased quality of life and long-term satisfaction. The best approach to integrating these two treatments has not been well-understood.

"It is critical to use these results to generate consensus about the optimal approaches to integrating radiation therapy and breast reconstruction so that women do not receive radically different recommendations based on where they happen to go for treatment," Jagsi says.


More Articles About: Lab Report Breast cancer Cancer: Cancer Types
Health Lab word mark overlaying blue cells
Health Lab

This article is from the Health Lab digital publication.

Media Contact Public Relations

Department of Communication at Michigan Medicine

MichMedmedia@med.umich.edu

734-764-2220

Newsletter

Get a weekly digest of medical research and innovation, straight to your inbox.

Subscribe
Featured News & Stories lymph nodes breast cancer under microscope
Health Lab
Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment
In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cancer.
older woman sitting in chair looking at window in white shirt
Health Lab
Patients with Metastatic Breast Cancer and High Mutational Burden Benefit from Pembrolizumab
Study findings support the recent FDA approval of the immunotherapy agent for patients whose cancers have high number of mutations.
Photo: Leisa Thompson
Health Lab
Women with Inflammatory Breast Cancer Are Living Longer, But the Gap Between White and Black Patients Persists
A U-M Rogel Cancer study provides an updated, more comprehensive look at trends for this rare, aggressive form of breast cancer over the last four decades.
Breast cancer cell
Health Lab
Approach to Personalizing Treatment of Triple-Negative Breast Cancer Shows Promise in Cell Lines
Researchers devise new approach to find drug-activity biomarkers in fight against triple-negative breast cancer.
Doctor looking at computer screen
Health Lab
Study: Aggressive Breast Cancers Store Large Amounts of Energy, Which Enables It to Spread
The finding suggests a potential target in the metabolism that could slow or prevent breast cancer metastasis.
Health Lab
By Cannibalizing Nearby Stromal Stem Cells, Some Breast Cancer Cells Gain Invasion Advantage
Cancer biologists and engineers collaborated on a device that could help predict the likelihood of breast cancer metastasis.